Cite
HARVARD Citation
von Einem, J. et al. (2019). Treatment of advanced gastrointestinal cancer with genetically modified autologous mesenchymal stem cells: Results from the phase 1/2 TREAT‐ME‐1 trial. International journal of cancer. 145 (6), pp. 1538-1546. [Online].